Impact of dendritic cells combining with cytokine-induced killer cells synergized chemotherapy in patients of advanced non-small cell lung cancer.

被引:0
|
作者
Zhong, Runbo [1 ]
Zhong, Hua [1 ]
Han, Baohui [1 ]
机构
[1] Shandong Prov Chest Hosp, Shanghai, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e19018
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Effectiveness and safety of chemotherapy with cytokine-induced killer cells in non-small cell lung cancer: A systematic review and meta-analysis of 32 randomized controlled trials
    Xiao, Zheng
    Wang, Cheng-Qiong
    Feng, Ji-Hong
    Zhou, Ming-Hua
    Wang, Yu-Zhi
    Li, Na-Na
    Sun, Yong-Ping
    Liu, Shi-Yu
    Yao, Xin-Sheng
    Li, Cheng-Wen
    Ma, Bin
    Ding, Jie
    Chen, Ling
    CYTOTHERAPY, 2019, 21 (02) : 125 - 147
  • [42] Autologous cytokine-induced killer and dentritic cells in treatment of advanced and unresectable lung cancer
    Zhang, Lei
    Li, Baoping
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [43] Immunological and clinical effects of post-surgical adjuvant chemotherapy and immunotherapy using autologous dendritic cells (DCs) induced cytokine-induced killer (CIK) cells for non-small-cell lung cancer (NSCLC) patients
    Li, Hui
    CANCER RESEARCH, 2009, 69
  • [44] Effect of cytokine-induced killer cells on immune function in patients with lung cancer
    Pan, Yanyan
    Wu, Yuanyuan
    Ji, Jun
    Cai, Hongjiao
    Wang, Heshuang
    Jiang, Yifan
    Sang, Limin
    Yang, Jin
    Gao, Yanyan
    Liu, Ying
    Yin, Liangwei
    Zhang, Li
    ONCOLOGY LETTERS, 2016, 11 (04) : 2827 - 2834
  • [45] Autologous cytokine-induced killer (CIK) cells enhance the clinical response to PD-1 blocking antibodies in patients with advanced non-small cell lung cancer: A preliminary study
    Han, Ying
    Mu, Di
    Liu, Ting
    Zhang, Huan
    Zhang, Jiali
    Li, Shuzhan
    Wang, Rui
    Du, Weijiao
    Hui, Zhenzhen
    Zhang, Xinwei
    Ren, Xiubao
    THORACIC CANCER, 2021, 12 (02) : 145 - 152
  • [46] Clinical Trials with Combination of Cytokine-Induced Killer Cells and Dendritic Cells for Cancer Therapy
    Garofano, Francesca
    Gonzalez-Carmona, Maria A.
    Skowasch, Dirk
    Schmidt-Wolf, Roland
    Abramian, Alina
    Hauser, Stefan
    Strassburg, Christian P.
    Schmidt-Wolf, Ingo G. H.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (17)
  • [47] Advanced non-small cell lung cancer.
    Edelman M.J.
    Khanwani S.L.
    Current Treatment Options in Oncology, 2001, 2 (1) : 51 - 62
  • [48] Chemotherapy in patients with advanced non-small cell lung cancer
    Price, A
    CLINICAL ONCOLOGY, 2001, 13 (06) : 480 - 482
  • [49] Rapid Response of Advanced Squamous Non-Small Cell Lung Cancer with Thrombocytopenia After First-Line Treatment with Pembrolizumab Plus Autologous Cytokine-Induced Killer Cells
    Hui, Zhenzhen
    Zhang, Xinwei
    Ren, Baozhu
    Li, Runmei
    Ren, Xiubao
    FRONTIERS IN IMMUNOLOGY, 2015, 6 : 1 - 5
  • [50] Clinical research of genetically modified dendritic cells in combination with cytokine-induced killer cell treatment in advanced renal cancer
    Danhong Wang
    Bin Zhang
    Haiyan Gao
    Guoliang Ding
    Qiong Wu
    Jinchao Zhang
    Li Liao
    Hu Chen
    BMC Cancer, 14